Shionogi Share Price Jumps After Report Of Crestor Cutting Heart Attack Risk
This article was originally published in PharmAsia News
Executive Summary
American Heart Association released a report Nov. 9 that reported cholesterol lowering drug Crestor (rosuvastatin) cut heart attack risk in people with low to normal cholesterol levels. In Tokyo, Shionogi's shares jumped over 11 percent upon hearing the news. (Click here for more - Japanese language